New technology for restoring vision in patients with retinal diseases
Massively Parallel Optoacoustic Retinal Stimulation at Micrometer-Resolution
['FUNDING_R21'] · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · NIH-10916519
This study is testing a new device that uses sound waves to help improve vision for people with retinal diseases, aiming to provide better results than current treatments.
Quick facts
| Phase | ['FUNDING_R21'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) (nih funded) |
| Locations | 1 site (BOSTON, UNITED STATES) |
| Trial ID | NIH-10916519 on ClinicalTrials.gov |
What this research studies
This research focuses on developing a novel optoacoustic micro-lens array that aims to improve vision restoration for individuals suffering from retinal degenerative diseases. By utilizing focused ultrasound, the technology seeks to stimulate retinal cells with high precision and pixel density, potentially offering a more effective alternative to current electrical-based retinal prostheses. The approach involves a multidisciplinary team that combines expertise in nanomaterials and neural interfaces to create a soft implant designed for better integration and performance. Patients may benefit from this innovative method that promises enhanced visual outcomes compared to existing treatments.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with retinal degenerative diseases who are experiencing significant vision loss.
Not a fit: Patients with non-retinal causes of vision loss or those who do not have retinal degenerative diseases may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve the quality of life for patients with vision loss due to retinal degenerative diseases.
How similar studies have performed: While the approach of using optoacoustic technology for retinal stimulation is innovative, similar technologies have shown promise in other areas of neural stimulation, indicating potential for success.
Where this research is happening
BOSTON, UNITED STATES
- BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) — BOSTON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: YANG, CHEN — BOSTON UNIVERSITY (CHARLES RIVER CAMPUS)
- Study coordinator: YANG, CHEN
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.